Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 4, Issue 2 (2015)

Qualitative & quantitative phytochemical assessment of #PPL/2013 capsules – A poly-herbal formulation for gynaecological disorders

Author(s):
Divya Gangolli, Rajashree Rane, Chetna Chotalia, Sachin Kundalwal, Kavita Salkar, Ashish Suthar
Abstract:
Now-a-days, gynaecological disorders in women have become extremely common due to hormonal imbalance caused by stress, birth control pills, genetics, obesity, lack of exercise and sedentary lifestyle. This research article focuses on the qualitative & quantitative phytochemical analysis of 10 different batches of a poly-herbal capsule formulation containing Lodhra, Haldi, Yashtimadhu and Shatavari all of these being extremely useful in curing gynaecological disorders. Initially, the 10 batches were subjected to physico-chemical tests like Disintegration Time, Average weight, Uniformity of Weight, Loss On Drying, Total Ash, Acid Insoluble Ash, Water Soluble Extractive, Alcohol Soluble Extractive and pH of 1% solution (w/v) in water. Subsequently, quantitative assays like Content of Tannins and Curcumin were carried out. Also, HPTLC fingerprinting of all the batches was carried out for identification purpose. Finally, Heavy metals and Microbiological count were analysed in all the samples. The results of all the parameters of the 10 batches were within the specified limits and also showed minimum batch to batch variation. This study proves that there is consistency in the commercial production batches of PPL/2013 Capsules and the end user (patient) can rely on the quality standard of the product for safe consumption.
Pages: 77-82  |  794 Views  5 Downloads
How to cite this article:
Divya Gangolli, Rajashree Rane, Chetna Chotalia, Sachin Kundalwal, Kavita Salkar, Ashish Suthar. Qualitative & quantitative phytochemical assessment of #PPL/2013 capsules – A poly-herbal formulation for gynaecological disorders. Pharma Innovation 2015;4(2):77-82.
The Pharma Innovation Journal